Leading Long COVID scientists, government officials, and advocates are meeting today and tomorrow in Bethesda, Maryland for the third annual RECOVER-Treating Long COVID (TLC) workshop, hosted by the ...

Together, they carry grief, sex, stigma, government abandonment, and the intimate devastation of lovers disappearing faster ...

Multiple COVID-19 precautions during the Tokyo Olympic and Paralympic Games were effective in minimizing SARS-CoV-2 transmission, according to a new study in Eurosurveillance. Using retrospective ...

Higher COVID-19 levels from the summer’s surge are still persisting through late October. Some regions where we thought the ...

For those who can work at all — around 8 in 10, one study found — accommodations are often what makes it possible. The costs ...

Novel anti-inflammatory drug shows early promise in treating Long COVID cognitive symptoms, fatigue, PEM. The study looked at multiple endpoints and consulted with people living with the disease.

This summer’s COVID-19 wave is still lingering into the fall, as much of the country reports ongoing moderate to high disease ...

Lynne Morioka shares how she created the mask-required, “outdoors first” Hearts and Minds Learning Community in Minneapolis, Minnesota. Photo courtesy Lynne Morioka “When do I get to go to big kid ...

While there are no data sources on Long COVID in prison, experts suspect rates of the disease may be higher there than in the general population. They face high reinfection risks and poor access to ...

This commentary article was originally published in The Gauntlet, a Substack publication by Julia Doubleday. The Sick Times has republished it with permission. Last week, The Telegraph published an ...

While the phase 2 clinical trial results, shared by BioVie in a webinar on Tuesday, have yet to be peer-reviewed, investigators say they can inform a confirmatory phase 3 trial. The novel drug ...